GE HealthCare Technologies Inc. $GEHC Stock Position Increased by Barrow Hanley Mewhinney & Strauss LLC

Barrow Hanley Mewhinney & Strauss LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 13.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,455,814 shares of the company's stock after purchasing an additional 1,571,226 shares during the period. GE HealthCare Technologies makes up 2.6% of Barrow Hanley Mewhinney & Strauss LLC's investment portfolio, making the stock its 3rd largest position. Barrow Hanley Mewhinney & Strauss LLC owned 2.98% of GE HealthCare Technologies worth $861,307,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in GEHC. Vanguard Group Inc. lifted its position in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company's stock worth $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Auto Owners Insurance Co boosted its position in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock worth $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Dodge & Cox increased its stake in GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company's stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares during the last quarter. Capital Research Global Investors raised its stake in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company's stock worth $2,080,248,000 after acquiring an additional 389,796 shares in the last quarter. Finally, State Street Corp increased its position in shares of GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company's stock worth $1,644,475,000 after purchasing an additional 401,932 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $74.82 on Monday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97. The company has a market cap of $33.80 billion, a P/E ratio of 17.16, a P/E/G ratio of 2.16 and a beta of 0.69. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a 50-day moving average of $66.61 and a 200-day moving average of $69.53.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The company had revenue of $5.29 billion during the quarter, compared to analysts' expectations of $5.26 billion. During the same period in the previous year, the company earned $1.06 EPS. The business's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies's payout ratio is currently 3.21%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent research reports. Argus cut their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a "buy" rating on the stock in a report on Tuesday, May 19th. Royal Bank Of Canada initiated coverage on GE HealthCare Technologies in a report on Tuesday, June 23rd. They issued an "outperform" rating and a $80.00 price target for the company. UBS Group boosted their price objective on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a "neutral" rating in a report on Friday, July 31st. Citigroup upped their target price on GE HealthCare Technologies from $69.00 to $75.00 and gave the company a "neutral" rating in a report on Thursday, July 30th. Finally, BMO Capital Markets initiated coverage on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a "market perform" rating and a $70.00 price target on the stock. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of "Hold" and a consensus target price of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source